Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Acelrx, Albireo, Biolinerx, Epitopoietic Research, Jaguar Health, Kamada, Merck, Northwest, PCI, Pluristem, Qu, Trefoil, Turning Point, Verona.

Biopharmas raising money in public or private financings, including: Curevac, Equillium, Eyenovia, Harmony, Inhibrx, Midatech, Royalty.

New hires and promotions in the biopharma industry, including: Byondis, Fate, Flexion, Kronos, Okyo, Rome, Tyme, Zyus.

Quarterly snapshots from biopharma companies with marketed products, including: Supernus.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Adamis, Antengene, Arca, Atyr, Eli Lilly, Enzychem Lifesciences, Equillium, Henlius, Hoth, Innovent, Kyorin, Mesoblast, Pliant, Redhill, Seattle Genetics, TLC, Verona.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Arcturus, Ascletis, Blade, Botanix, GNI Group, I-Mab, Merck, Novavax, Romark Laboratories, SAB, Syndax.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: AGC Biologics, Aicuris Anti-infective Cures, Ajinomoto Bio-Pharma Services, Anixa, Arctic Vision, Beyondspring, Bioaegis, Biological E., Bold, Bridgebio, Caribou Biosciences, Carsgen, Cerecor, Certara, Dr. Falk, Dynavax, Eyenovia, Genscript, Heat Biologics, Hifibio, Innate, Isofol Medical, Janone, JN Nova, Kiadis, Lianbio, Memo, Merck, Molecular Partners, Monopar, Novavax, Novome, Ono, Ontochem, Ose Immunotherapeutics, Pluristem, Prometheus, Qbiotics, Revive, Saillant, SK Group, Solasia, Tevogen, Xbiotech.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Atriva, Genome and Co., Scioto, Organicell Regenerative Medicine.

Quarterly snapshots from biopharma companies with marketed products, including: Zai Lab.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Zai Lab.